Therapeutics Ocumension Eye Point Pharmaceuticals, Inc. (EYPT) insider trading activity

EYPT Quotes by TradingView

Therapeutics Ocumension is Director of EyePoint Pharmaceuticals, Inc.. Currently has a direct ownership of 100,221 shares of EYPT, which is worth approximately $711,569. The most recent transaction as insider was on Jan 11, 2024, when has been sold 1,910,500 shares (Common Stock) at a price of $19.45 per share, resulting in proceeds of $37,159,225. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100K
0% 3M change
95.02% 12M change
Total Value Held $711,569

Therapeutics Ocumension Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 11 2024
SELL
Open market or private sale
$37,159,225 $19.45 p/Share
1,910,500 Reduced 95.02%
100,221 Common Stock
Dec 06 2023
SELL
Open market or private sale
$4,901,515 $18.41 p/Share
266,242 Reduced 11.69%
2,010,721 Common Stock
Dec 05 2023
SELL
Open market or private sale
$14,609,121 $19.91 p/Share
733,758 Reduced 24.37%
2,276,963 Common Stock
TO

Therapeutics Ocumension

Director
Jing'An District, Shanghai, F4

Track Institutional and Insider Activities on EYPT

Follow EyePoint Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EYPT shares.

Notify only if

Insider Trading

Get notified when an Eye Point Pharmaceuticals, Inc. insider buys or sells EYPT shares.

Notify only if

News

Receive news related to EyePoint Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EYPT